The Senate Tick Act (Collins, ME) was passed out of the Senate HELP Committee; however, it was a different bill than the one that was originally submitted to the Senate Committee that many Lyme groups supported. The HELP committee replaced it in its entirety with a Manager’s Amendment, submitted “in the nature of a substitute,” which still keeps the same bill number, S-1657, and it was renamed the Kay Hagan Tick Act. For more information and action to take…
This section contains information on legislation that has been introduced and/or passed by the federal government. It includes sections that contain the position the Lyme Disease Association (LDA) has taken on various bills, if any, and information on how to contact your legislator; and what you can do to help specific laws be passed or defeated. Additionally, there is a section on various government departments. From time to time, the LDA will post articles from the departments/agencies in these sections that pertain to Lyme disease that might be of interest or importance to the public, including policies being considered or adopted.
It is important for the LDA to take a lead role in forming relationships with all levels of government. Laws and policy decisions often affect how Lyme disease is viewed by the public and physicians, and LDA needs to clearly articulate the problems which are created by government actions or which can be rectified by government actions. Additionally, we need to ensure that the information presented to government officials is accurate and supported by science.
Explanation of Tick Act Changes From the Lyme Disease Association & How To Help On October 31, the Senate Tick Act (Collins ME) was passed out of the Senate HELP Committee; however, it was a different bill than the one submitted to the Senate Committee that many Lyme groups supported. The HELP committee replaced it […]
Almost a decade ago, Lyme advocates in Minnesota, pursuing Lyme doctor protection legislation, settled for a compromise from the State Medical Board which issued a Moratorium taking action against doctors who treat long term. The Moratorium was reviewed and extended in 2014, while awaiting more research on the topic. According to the Minneapolis Star Tribune, […]
From Department of Defense – CDMRP: Nicole Malachowski recently medically retired from the US Air Force as a Colonel after 21 years of service as a career fighter pilot. She was the first woman in history to fly with the Thunderbirds (US Air Force Demonstration Squadron) and went on to be the Commander of the […]
From the LDA, October 25, 2019 A press conference was held at the Wall Township Municipal Complex hosted by Congressman Christopher Smith (R-NJ). The Congressman highlighted information on the “NIH Strategic Plan for Tick-Borne Disease Research,” as well as “The Tick Act,” a bipartisan effort to improve research, prevention, diagnostics, and treatment for tick-borne diseases. […]
Read below or Click here for Dr. Robert Bransfield’s Speech – Pennsylvania HB629 Rally I am a psychiatrist in New Jersey who has treated thousands of Lyme patients in the past 30 years and many have come from Pennsylvania. I am here to support passage of Pennsylvania HB629. Our greatest resource is our human capability and productivity and that is being jeopardized by an epidemic of inadequately diagnosed and inadequately treated tickborne diseases in children and adults.
The NIH Strategic Plan for Tickborne Disease Research, October 9, 2019, is good news for everyone in the Lyme and tick-borne diseases community! The plan builds on the activities of the Department of Health and Human Services Tick-Borne Disease Working Group (TBDWG), which issued a 2018 report to Congress outlining research recommendations. Through inventories sent […]
The tenth meeting of the Tick-Borne Disease Working Group (TBDWG) was held via webcast on Sept 12, 2019 from 9:00 a.m. to 3:00 p.m. ET. Subcommittee members were announced, and the Working Group received reports from the eight subcommittees that were formed during the June 4, 2019 meeting. Two subcommittee name changes were […]
The CDC formally recommends several new serologic assay testing methods recently cleared by the FDA. The Lyme disease serologic assays, which utilize a sensitive enzyme immunoassay (EIA) for detecting pathogens, were cleared by the FDA on July 29th, 2019 and have since been determined to be acceptable alternatives for the serologic diagnosis of Lyme disease […]